 Andrea Dlugos
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Stimulants | 4 | 2010 | 206 | 1.110 |
Why?
| | Dextroamphetamine | 5 | 2010 | 111 | 1.030 |
Why?
| | Amphetamine | 3 | 2010 | 103 | 0.940 |
Why?
| | Norepinephrine Plasma Membrane Transport Proteins | 2 | 2009 | 6 | 0.820 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2011 | 2176 | 0.760 |
Why?
| | Emotions | 4 | 2014 | 258 | 0.650 |
Why?
| | Arousal | 3 | 2014 | 163 | 0.540 |
Why?
| | Ethanolamines | 1 | 2012 | 33 | 0.530 |
Why?
| | Stress, Psychological | 2 | 2012 | 284 | 0.500 |
Why?
| | Receptors, Opioid, mu | 1 | 2010 | 44 | 0.470 |
Why?
| | Euphoria | 1 | 2010 | 47 | 0.470 |
Why?
| | Amidohydrolases | 1 | 2009 | 18 | 0.450 |
Why?
| | Monoamine Oxidase | 1 | 2009 | 23 | 0.440 |
Why?
| | Fatigue | 1 | 2009 | 159 | 0.410 |
Why?
| | Personality | 1 | 2009 | 115 | 0.390 |
Why?
| | Genetic Variation | 3 | 2010 | 1303 | 0.390 |
Why?
| | Genotype | 10 | 2014 | 1777 | 0.370 |
Why?
| | Haplotypes | 4 | 2010 | 622 | 0.350 |
Why?
| | Cross-Over Studies | 4 | 2010 | 381 | 0.340 |
Why?
| | Adolescent | 10 | 2012 | 8393 | 0.320 |
Why?
| | Double-Blind Method | 7 | 2014 | 1766 | 0.310 |
Why?
| | Young Adult | 10 | 2012 | 5194 | 0.310 |
Why?
| | Polymorphism, Genetic | 4 | 2014 | 818 | 0.280 |
Why?
| | Alleles | 3 | 2014 | 1067 | 0.280 |
Why?
| | Catechol O-Methyltransferase | 3 | 2014 | 57 | 0.280 |
Why?
| | Caffeine | 3 | 2012 | 78 | 0.270 |
Why?
| | Adult | 14 | 2014 | 23950 | 0.240 |
Why?
| | Affect | 4 | 2012 | 376 | 0.220 |
Why?
| | Heart Rate | 2 | 2012 | 484 | 0.210 |
Why?
| | European Continental Ancestry Group | 3 | 2009 | 1022 | 0.210 |
Why?
| | Male | 15 | 2016 | 38702 | 0.190 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2012 | 440 | 0.190 |
Why?
| | Female | 15 | 2016 | 40918 | 0.190 |
Why?
| | Plasmodium berghei | 1 | 2016 | 1 | 0.180 |
Why?
| | Malaria, Cerebral | 1 | 2016 | 2 | 0.180 |
Why?
| | Chemokine CCL17 | 1 | 2016 | 2 | 0.180 |
Why?
| | Receptor, Cannabinoid, CB2 | 1 | 2016 | 4 | 0.180 |
Why?
| | Blood-Brain Barrier | 1 | 2016 | 60 | 0.180 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 472 | 0.170 |
Why?
| | Anxiety | 3 | 2014 | 214 | 0.170 |
Why?
| | Receptor, Adenosine A2A | 2 | 2012 | 14 | 0.160 |
Why?
| | Dopamine | 1 | 2014 | 285 | 0.140 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2012 | 8 | 0.140 |
Why?
| | Receptors, Neuropeptide | 1 | 2012 | 8 | 0.130 |
Why?
| | Analysis of Variance | 2 | 2012 | 947 | 0.130 |
Why?
| | Humans | 14 | 2014 | 74544 | 0.130 |
Why?
| | Neuropeptides | 1 | 2012 | 120 | 0.120 |
Why?
| | Stimulation, Chemical | 1 | 2010 | 68 | 0.120 |
Why?
| | Gene Frequency | 2 | 2009 | 646 | 0.120 |
Why?
| | Hydrocortisone | 1 | 2012 | 299 | 0.120 |
Why?
| | Chromosomes | 1 | 2010 | 94 | 0.120 |
Why?
| | Acute Disease | 1 | 2012 | 822 | 0.110 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2010 | 35 | 0.110 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 33 | 0.110 |
Why?
| | Lipids | 1 | 2012 | 376 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 2010 | 55 | 0.110 |
Why?
| | Hormones | 1 | 2010 | 119 | 0.110 |
Why?
| | Receptors, Dopamine D2 | 1 | 2009 | 64 | 0.110 |
Why?
| | Wakefulness | 1 | 2009 | 119 | 0.110 |
Why?
| | Amino Acid Substitution | 1 | 2010 | 351 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 1178 | 0.100 |
Why?
| | Genetic Association Studies | 1 | 2009 | 261 | 0.090 |
Why?
| | Substance-Related Disorders | 1 | 2010 | 349 | 0.090 |
Why?
| | Psychological Tests | 1 | 2007 | 86 | 0.090 |
Why?
| | Attention | 1 | 2010 | 327 | 0.090 |
Why?
| | Impulsive Behavior | 1 | 2009 | 219 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2009 | 857 | 0.080 |
Why?
| | Blood Pressure | 1 | 2010 | 1128 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 890 | 0.080 |
Why?
| | African Continental Ancestry Group | 1 | 2007 | 539 | 0.070 |
Why?
| | Depression | 1 | 2007 | 354 | 0.070 |
Why?
| | Time Factors | 1 | 2012 | 5214 | 0.070 |
Why?
| | DNA | 1 | 2007 | 1271 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2010 | 431 | 0.050 |
Why?
| | Mannose-Binding Lectins | 1 | 2016 | 4 | 0.050 |
Why?
| | Arginase | 1 | 2016 | 15 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2016 | 92 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2016 | 153 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2016 | 139 | 0.040 |
Why?
| | Neutrophils | 1 | 2016 | 252 | 0.040 |
Why?
| | Carbidopa | 1 | 2014 | 5 | 0.040 |
Why?
| | Levodopa | 1 | 2014 | 33 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 287 | 0.040 |
Why?
| | Drug Combinations | 1 | 2014 | 219 | 0.040 |
Why?
| | Macrophages | 1 | 2016 | 517 | 0.030 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2012 | 3 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2016 | 1821 | 0.030 |
Why?
| | Luteal Phase | 1 | 2010 | 17 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2009 | 39 | 0.030 |
Why?
| | Personality Inventory | 1 | 2009 | 94 | 0.030 |
Why?
| | Placebos | 1 | 2010 | 217 | 0.030 |
Why?
| | Area Under Curve | 1 | 2010 | 333 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2016 | 2114 | 0.030 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 165 | 0.030 |
Why?
| | Reaction Time | 1 | 2009 | 294 | 0.030 |
Why?
| | Sex Factors | 1 | 2011 | 1040 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2010 | 287 | 0.020 |
Why?
| | Psychomotor Performance | 1 | 2009 | 477 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 2010 | 359 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2041 | 0.020 |
Why?
| | Mice | 1 | 2016 | 10349 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2011 | 2044 | 0.020 |
Why?
| | Animals | 1 | 2016 | 25421 | 0.010 |
Why?
|
|
Dlugos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|